Therapeutic agent for glaucoma containing adenosine derivative as active ingredient

Details for Australian Patent Application No. 2008241496 (hide)

Owner Santen Pharmaceutical Co., Ltd. PGxHealth, LLC

Inventors Thompson, Robert D.; Kawabata, Noriko; Shimazaki, Atsushi; Rieger, Jayson M.; Kirihara, Tomoko

Agent IP Gateway Patent and Trademark Attorneys

Pub. Number AU-A-2008241496

PCT Pub. Number WO2008/130520

Priority 2007-106915 16.04.07 JP

Filing date 14 April 2008

Wipo publication date 30 October 2008

International Classifications

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/70 (2006.01) - Carbohydrates

Event Publications

3 December 2009 PCT application entered the National Phase

  PCT publication WO2008/130520 Priority application(s): WO2008/130520

3 May 2012 Assignment before Grant

  Santen Pharmaceutical Co., Ltd.; PGxHealth, LLC The application has been assigned to Forest Laboratories Holdings Limited; Santen Pharmaceutical Co., Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008241500-Aryl heterocyclic CGRP receptor antagonists

2008241490-Substituted biphenyl phenoxy-, thiophenyland aminophenylpropanoic acid GPR40 modulators